295 related articles for article (PubMed ID: 16859527)
1. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.
Iwasaki T; Imado T; Kitano S; Sano H
Arthritis Res Ther; 2006; 8(6):R161. PubMed ID: 17049072
[TBL] [Abstract][Full Text] [Related]
3. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
4. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
[TBL] [Abstract][Full Text] [Related]
5. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
6. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
[TBL] [Abstract][Full Text] [Related]
7. Non-MHC genes determine the development of lupus nephritis in H-2 identical mouse strains.
Sutmuller M; Ekstijn GL; Ouellette S; De Heer E; Bruijn JA
Clin Exp Immunol; 1996 Nov; 106(2):265-72. PubMed ID: 8918572
[TBL] [Abstract][Full Text] [Related]
8. Sialoadenitis in experimental graft-versus-host disease. An animal model of Sjögren's syndrome.
Fujiwara K; Sakaguchi N; Watanabe T
Lab Invest; 1991 Dec; 65(6):710-8. PubMed ID: 1753714
[TBL] [Abstract][Full Text] [Related]
9. CD28 knockout mice as a useful clue to examine the pathogenesis of chronic graft-versus-host reaction.
Ogawa S; Nitta K; Hara Y; Horita S; Nihei H; Abe R
Kidney Int; 2000 Nov; 58(5):2215-20. PubMed ID: 11044244
[TBL] [Abstract][Full Text] [Related]
10. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome.
Santiago ML; Fossati L; Jacquet C; Müller W; Izui S; Reininger L
J Exp Med; 1997 Jan; 185(1):65-70. PubMed ID: 8996242
[TBL] [Abstract][Full Text] [Related]
12. Histopathological changes in exocrine glands of murine transplantation chimeras. I: The development of Sjögren's syndrome-like changes secondary to GVH induced lupus syndrome.
Sørensen I; Ussing AP; Prause JU; Blom J; Larsen S; Spärck JV
Autoimmunity; 1992; 11(4):261-71. PubMed ID: 1581471
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
14. Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis.
Bergijk EC; Baelde HJ; de Heer E; Bruijn JA
Kidney Int; 1994 Dec; 46(6):1663-73. PubMed ID: 7700025
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
16. Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference.
Ito S; Ueno M; Nishi S; Arakawa M; Ikarashi Y; Saitoh T; Fujiwara M
Autoimmunity; 1992; 12(2):79-87. PubMed ID: 1617113
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction.
Itoh S; Matsuzaki Y; Kimura T; Ikegami T; Shoda J; Fujiwara M; Tanaka N
J Gastroenterol Hepatol; 2000 Apr; 15(4):443-51. PubMed ID: 10824891
[TBL] [Abstract][Full Text] [Related]
18. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
Laurent L; Le Fur A; Bloas RL; Néel M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F
Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301
[TBL] [Abstract][Full Text] [Related]
19. Quercitrin ameliorates the development of systemic lupus erythematosus-like disease in a chronic graft-versus-host murine model.
Li W; Li H; Zhang M; Wang M; Zhong Y; Wu H; Yang Y; Morel L; Wei Q
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F217-26. PubMed ID: 26911849
[TBL] [Abstract][Full Text] [Related]
20. IL-18 prevents the development of chronic graft-versus-host disease in mice.
Okamoto I; Kohno K; Tanimoto T; Iwaki K; Ishihara T; Akamatsu S; Ikegami H; Kurimoto M
J Immunol; 2000 Jun; 164(11):6067-74. PubMed ID: 10820292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
